Prevention of senescence progression in reversibly immortalized human ensheathing glia permits their survival after deimmortalization

Molecular Therapy

Volumn 18, Issue 2, 2010, Pages 394-403

  García Escudero, Vega ^a,b   García Gómez, Ana ^b   Gargini, Ricardo ^b   Martín Bermejo, María J ^b   Langa, Elena ^b   De Yébenes, Justo G ^c   Delicado, Alicia ^d   Vila, Jess ^b   Moreno Flores, María T ^b   Lim, Filip ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; CRE RECOMBINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; LENTIVIRUS VECTOR; PROTEIN P53; SHORT HAIRPIN RNA; TELOMERASE; VIRUS T ANTIGEN;

ADOLESCENT; ARTICLE; CADAVER; CATALYSIS; CELL CULTURE; CELL DIVISION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE TRANSFER; GLIA CELL; GROWTH DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LOXP SITE; OLFACTORY BULB; OLFACTORY ENSHEATHING CELL; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE;

ADOLESCENT; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BLOTTING, WESTERN; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LENTIVIRUS; NUCLEAR PROTEINS; OLFACTORY BULB; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 76349094269     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.268     Document Type: Article

References (41)

1. Bodnar, AG, Ouellette, M, Frolkis, M, Holt, SE, Chiu, CP, Morin, GB, et al. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
2. Salmon, P, Oberholzer, J, Occhiodoro, T, Morel, P, Lou, J and Trono, D (2000). Reversible immortalization of human primary cells by lentivector-mediated transfer of specifc genes. Mol Ther 2: 404-414.
3. Westerman, KA and Leboulch, P (1996). Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specifc recombination. Proc Natl Acad Sci USA 93: 8971-8976.
4. Takahashi, K and Yamanaka, S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126: 663-676.
5. Lowry, WE and Plath, K (2008). The many ways to make an iPS cell. Nat Biotechnol 26: 1246-1248.
6. Feng, R, Desbordes, SC, Xie, H, Tillo, ES, Pixley, F, Stanley, ER, et al. (2008). PU.1 and C/EBPalpha/beta convert fbroblasts into macrophage-like cells. Proc Natl Acad Sci USA 105: 6057-6062.
7. Weintraub, H, Tapscott, SJ, Davis, RL, Thayer, MJ, Adam, MA, Lassar, AB, et al. (1989). Activation of muscle-specifc genes in pigment, nerve, fat, liver, and fbroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 86: 5434-5438.
8. Zhou, Q, Brown, J, Kanarek, A, Rajagopal, J and Melton, DA (2008). In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455: 627-632.
9. Raisman, G and Li, Y (2007). Repair of neural pathways by olfactory ensheathing cells. Nat Rev Neurosci 8: 312-319.
10. Moreno-Flores, MT, Díaz-Nido, J, Wandosell, F and Avila, J (2002). Olfactory ensheathing glia: drivers of axonal regeneration in the central nervous system? J Biomed Biotechnol 2: 37-43.
11. Ali, SH and DeCaprio, JA (2001). Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol 11: 15-23.
12. Park, IK, Morrison, SJ and Clarke, MF (2004). Bmi1, stem cells, and senescence regulation. J Clin Invest 113: 175-179.
13. Szulc, J, Wiznerowicz, M, Sauvain, MO, Trono, D and Aebischer, P (2006). A versatile tool for conditional gene expression and knockdown. Nat Methods 3: 109-116.
14. Harper, JW, Elledge, SJ, Keyomarsi, K, Dynlacht, B, Tsai, LH, Zhang, P, et al. (1995). Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387-400.
15. Li, L, Zhou, S, Chen, X, Guo, L, Li, Z, Hu, D, et al. (2008). The activation of p53 mediated by Epstein-Barr virus latent membrane protein 1 in SV40 large T-antigen transformed cells. FEBS Lett 582: 755-762.
16. O'Neill, FJ, Hu, Y, Chen, T and Carney, H (1997). Identifcation of p53 unbound to T-antigen in human cells transformed by simian virus 40 T-antigen. Oncogene 14: 955-965.
17. Markovics, JA, Carroll, PA, Robles, MT, Pope, H, Coopersmith, CM and Pipas, JM (2005). Intestinal dysplasia induced by simian virus 40 T antigen is independent of p53. J Virol 79: 7492-7502.
18. Hara, E, Smith, R, Parry, D, Tahara, H, Stone, S and Peters, G (1996). Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867.
19. Huschtscha, LI and Reddel, RR (1999). p16(INK4a) and the control of cellular proliferative life span. Carcinogenesis 20: 921-926.
20. Polyak, K, Lee, MH, Erdjument-Bromage, H, Koff, A, Roberts, JM, Tempst, P, et al. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
21. Toyoshima, H and Hunter, T (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
22. Bringold, F and Serrano, M (2000). Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 35: 317-329.
23. Macmillan-Crow, LA and Cruthirds, DL (2001). Invited review: manganese superoxide dismutase in disease. Free Radic Res 34: 325-336.
24. Li, SK, Smith, DK, Leung, WY, Cheung, AM, Lam, EW, Dimri, GP, et al. (2008). FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J Biol Chem 283: 16545-16553.
25. Ahmed, S, Passos, JF, Birket, MJ, Beckmann, T, Brings, S, Peters, H, et al. (2008). Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 121: 1046-1053.
26. Moreno-Flores, MT, Lim, F, Martín-Bermejo, MJ, Díaz-Nido, J, Avila, J and Wandosell, F (2003). Immortalized olfactory ensheathing glia promote axonal regeneration of rat retinal ganglion neurons. J Neurochem 85: 861-871.
27. Loonstra, A, Vooijs, M, Beverloo, HB, Allak, BA, van Drunen, E, Kanaar, R, et al. (2001). Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98: 9209-9214.
28. Silver, DP and Livingston, DM (2001). Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8: 233-243.
29. Baba, Y, Nakano, M, Yamada, Y, Saito, I and Kanegae, Y (2005). Practical range of effective dose for Cre recombinase-expressing recombinant adenovirus without cell toxicity in mammalian cells. Microbiol Immunol 49: 559-570.
30. Lundberg, AS, Hahn, WC, Gupta, P and Weinberg, RA (2000). Genes involved in senescence and immortalization. Curr Opin Cell Biol 12: 705-709.
31. Carnero, A, Hudson, JD, Price, CM and Beach, DH (2000). p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2: 148-155.
32. Beauséjour, CM, Krtolica, A, Galimi, F, Narita, M, Lowe, SW, Yaswen, P, et al. (2003). Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 22: 4212-4222.
33. Campisi, J and d'Adda di Fagagna, F (2007). Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
34. Fridman, AL and Tainsky, MA (2008). Critical pathways in cellular senescence and immortalization revealed by gene expression profling. Oncogene 27: 5975-5987.
35. Hayfick, L (1965). The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614-636.
36. Lim, F, Martín-Bermejo, MJ, García-Escudero, V, Gallego-Hernández, MT, García-Gómez, A, Rábano, A, et al. Reversibly immortalized human olfactory ensheathing glia from an elderly donor maintain neuroregenerative capacity. Glia (in the press).
37. Kondziolka, D, Steinberg, GK, Wechsler, L, Meltzer, CC, Elder, E, Gebel, J, et al. (2005). Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 103: 38-45.
38. Dull, T, Zufferey, R, Kelly, M, Mandel, RJ, Nguyen, M, Trono, D, et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
39. Cudré-Mauroux, C, Occhiodoro, T, König, S, Salmon, P, Bernheim, L and Trono, D (2003). Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a duchenne myoblast cell line with long-term genotypic and phenotypic stability. Hum Gene Ther 14: 1525-1533.
40. Mosmann, T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
41. Seabright, M (1971). A rapid banding technique for human chromosomes. Lancet 2: 971-972.